hyaluronic acid
Commercial- Indications
- Cosmetic
Company intelligence / Profile preview
INNERBLOOM Med Spa offers FDA-approved injectable treatments including Botox®, Dysport®, hyaluronic acid-based dermal fillers, and weight loss injections such as semaglutide and tirzepatide. The company focuses on non-surgical facial aesthetics and medically supervised weight management in a clinical setting led by a registered nurse. No clinical trial data; all products are approved for commercial use.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INNERBLOOM Med Spa.